北美市场强劲表现助推飞利浦(PHG.US)Q3可比销售增长3% 经调整EBITA超预期

智通财经APP获悉，荷兰医疗科技企业飞利浦(PHG.US)周二公布了其2025年第三季度业绩。数据显 示，飞利浦Q3销售额同比下降2%至43.02亿欧元，符合市场普遍预期;可比销售额增长3%，其中北美地 区可比销售额增长5%。经调整后的息税摊销前利润(EBITA)为5.31亿欧元，好于市场预期的4.84亿欧 元。调整后的每股收益为0.36欧元。 | | Q3 2024 | Q3 2025 | | --- | --- | --- | | Sales | 4,377 | 4,302 | | Nominal sales growth | (2%) | (2%) | | Comparable sales growth 1 | 0% | 3% | | Comparable order intake 2 | (2%) | 8% | | Income from operations | 337 | 330 | | as a % of sales | 8% | 8% | | Financial income (expenses), net | (ea) | (57) | | Investments in associates ...